Drugs@FDA: FDA Approved Drug Products

Home | Previous Page

New Drug Application (NDA): 207202
Company: OTSUKA PHARM CO LTD
Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status TE Code RLD RS
ABILIFY MYCITE ARIPIPRAZOLE 2MG TABLET; ORAL W/SENSOR Prescription None TBD No
ABILIFY MYCITE ARIPIPRAZOLE 5MG TABLET; ORAL W/SENSOR Prescription None TBD No
ABILIFY MYCITE ARIPIPRAZOLE 10MG TABLET; ORAL W/SENSOR Prescription None TBD No
ABILIFY MYCITE ARIPIPRAZOLE 15MG TABLET; ORAL W/SENSOR Prescription None TBD No
ABILIFY MYCITE ARIPIPRAZOLE 20MG TABLET; ORAL W/SENSOR Prescription None TBD No
ABILIFY MYCITE ARIPIPRAZOLE 30MG TABLET; ORAL W/SENSOR Prescription None TBD No
Original Approvals or Tentative Approvals
Action Date Submission Action Type Submission Classification Review Priority; Orphan Status Letters, Reviews, Labels, Patient Package Insert Notes Url
11/13/2017 ORIG-1 Approval Type 4 - New Combination STANDARD Label (PDF)
Letter (PDF)
https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/207202lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2017/207202Orig1s000ltr.pdf
Action Date Submission Supplement Categories or Approval Type Letters, Reviews, Labels,
Patient Package Insert
Note Url
11/13/2017 ORIG-1 Approval Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/207202lbl.pdf

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English